Search clinical trials for: Immune Globulin Subcutaneous (Human), 20%
Total 950 results
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Diabetic Kidney Disease | Adolescent Obesity | Puberty | Pre Diabetes | Kidney HypoxiaUnited States
-
Medical Research Foundation, The NetherlandsMedtronicCompletedDiabetes Mellitus, Type 1Netherlands
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
Christchurch Women's HospitalCompletedHyperglycaemiaNew Zealand
-
PfizerCompletedDiabetes Mellitus, Type 1United States, Canada
-
Halozyme TherapeuticsCompleted
-
Drugs for Neglected DiseasesMakerere University; The Netherlands Cancer Institute; Kenya Medical Research... and other collaboratorsCompletedVisceral LeishmaniasisEthiopia, Kenya, Sudan, Uganda
-
Novo Nordisk A/SCompletedHealthy | DiabetesUnited Kingdom
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 2 Diabetes MellitusUnited States
-
University of AarhusAarhus University Hospital; Regionshospitalet SilkeborgCompletedType 2 Diabetes Mellitus
-
University of AarhusAarhus University Hospital; Regionshospitalet SilkeborgCompletedType 2 Diabetes MellitusDenmark
-
University Hospital TuebingenGerman Research FoundationUnknownHuman Physiology of Energy HomeostasisGermany
-
PfizerCompletedDiabetes Mellitus, Type 1United States, Canada
-
State University of New York - Downstate Medical...TerminatedDiabetes Mellitus | End-Stage Renal DiseaseUnited States
-
University of Colorado, DenverVeloxis PharmaceuticalsTerminatedKidney Transplant RejectionUnited States
-
University of UtahNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Novo Nordisk A/SCompletedComparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesDiabetes | Diabetes Mellitus, Type 1Malaysia, Australia, Hong Kong, Philippines
-
Orrin M Troum, M.D. and Medical AssociatesBristol-Myers SquibbCompletedRheumatoid ArthritisUnited States
-
Aristotle University Of ThessalonikiUniversity Hospital TuebingenCompletedDiabetes Mellitus, Type 2
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia
-
University Medical Center GroningenBristol-Myers SquibbCompletedSjögren's SyndromeNetherlands
-
Transdermal Delivery Solutions CorpLangford Research Institute, Inc.CompletedPharmacodynamic Response to Small Doses of InsulinUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
University Hospital TuebingenCompleted
-
Novo Nordisk A/SCompleted
-
University of Sao PauloCompletedHeart Valve Diseases | Ventricular Dysfunction | Hyperglycaemia During Perioperative PeriodBrazil
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndonesia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
John H. Stroger HospitalEli Lilly and CompanyCompleted
-
Inova Health Care ServicesTerminated
-
University Hospital TuebingenCompleted
-
Vanderbilt UniversityWithdrawn
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Hungary, Greece, Germany, Turkey, Romania, Czech Republic, Slovakia, Austria, Poland
-
PfizerSanofi; Nektar TherapeuticsCompletedDiabetes Mellitus, Type 2United States, Canada
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., LtdCompletedSafety, Immunogenicity
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico
-
Université NAZI BONIJuvenile Diabetes Research Foundation; International Society for Pediatric... and other collaboratorsRecruitingType 1 DiabetesBurkina Faso
-
Bristol-Myers SquibbCompletedDermatomyositis | Polymyositis | Autoimmune Necrotizing Myopathy | Overlap Myositis | Juvenile Myositis Above the Age of 18France, United States, Australia, Brazil, Czechia, Germany, Italy, Japan, Korea, Republic of, Mexico, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
The Hospital for Sick ChildrenBayerCompletedImmune Thrombocytopenic PurpuraCanada
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Russian Federation, Canada, Denmark, India, Poland, Korea, Republic of, Brazil, Argentina, Mexico, South Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria
-
Medical University of GrazCompletedType 1 Diabetes MellitusAustria
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa, United Arab Emirates, India
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
University of AarhusCompletedObesity | DyslipidemiaDenmark
-
PfizerTerminatedDiabetes Mellitus, Type 2Singapore, Hong Kong, Philippines, Pakistan